Stockscreener 앱 받기
1.79
16.99%
0.26
시간 외 거래:
1.83
0.04
+2.23%
전일 마감가:
$1.53
열려 있는:
$1.57
하루 거래량:
9.15M
Relative Volume:
2.26
시가총액:
$283.49M
수익:
-
순이익/손실:
$-110.78M
주가수익비율:
-1.6729
EPS:
-1.07
순현금흐름:
$-75.59M
1주 성능:
+19.33%
1개월 성능:
-0.56%
6개월 성능:
-42.81%
1년 성능:
-66.48%
1일 변동 폭
$1.57
$1.88
1주일 범위
$1.45
$1.88
52주 변동 폭
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.79 | 243.02M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-27 | 개시 | Barclays | Overweight |
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
Death Cross: Will Humacyte Inc Equity Warrant outperform its industry peersWeekly Trade Report & Safe Capital Investment Plans - خودرو بانک
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback - Benzinga
Humacyte’s engineered vessel shows promise in coronary bypass study - Investing.com India
Aug Selloffs: How much upside does Humacyte Inc. haveMarket Activity Report & Expert Verified Movement Alerts - خودرو بانک
Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG) - The Manila Times
Breakthrough in Heart Surgery: Humacyte's Bioengineered Vessel Maintains Perfect Blood Flow for 6 Months - Stock Titan
Humacyte Amends Revenue Agreement with TPC Investments - TipRanks
Trend Review: Can Humacyte Inc. deliver consistent dividendsInflation Watch & Risk Controlled Stock Alerts - خودرو بانک
Woodline Partners LP Raises Holdings in Humacyte, Inc. $HUMA - MarketBeat
Humacyte’s Big Bet On Next-Gen Vascular Grafts Faces Huge Hurdles - Finimize
Aug Final Week: Will Humacyte Inc Equity Warrant outperform its industry peersJuly 2025 Levels & Real-Time Market Sentiment Alerts - خودرو بانک
Recap Report: What is the dividend yield of VIVK2025 Earnings Impact & Fast Gain Stock Tips - خودرو بانک
Aug Outlook: Will Humacyte Inc Equity Warrant outperform its industry peersTrade Entry Report & Safe Entry Momentum Stock Tips - خودرو بانک
Earnings Beat: Can Humacyte Inc. scale operations efficientlyPortfolio Gains Report & Real-Time Market Trend Scan - خودرو بانک
Institution Moves: Does Humacyte Inc. stock have upside surprise potential - خودرو بانک
Signal Recap: Can Humacyte Inc deliver consistent EPS growthWeekly Loss Report & Reliable Volume Spike Alerts - خودرو بانک
Performance Recap: Will Humacyte Inc Equity Warrant outperform its industry peers2025 EndofYear Setup & Consistent Return Strategy Ideas - خودرو بانک
Market Outlook: Does Humacyte Inc have a sustainable dividendPortfolio Gains Report & Real-Time Stock Entry Alerts - خودرو بانک
Aug Action: Is Humacyte Inc a speculative investmentTrade Analysis Summary & AI Forecast for Swing Trade Picks - خودرو بانک
Block Trades: Is Humacyte Inc Equity Warrant a strong growth stockWeekly Profit Report & Growth Oriented Trading Recommendations - خودرو بانک
Risk Report: What analysts say about Humacyte Inc Equity Warrant stock2025 Biggest Moves & Risk Managed Investment Entry Signals - خودرو بانک
Humacyte's (HUMA) "Buy" Rating Reiterated at D. Boral Capital - MarketBeat
Quarterly Trades: Will EPIX outperform its industry peers2025 Growth vs Value & Daily Market Momentum Tracking - خودرو بانک
Risks Report: Whats the fair value of Humacyte Inc Equity Warrant stockTrade Volume Report & Consistent Return Investment Signals - خودرو بانک
MACD Signal: Whats the fair value of Humacyte Inc stockJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - خودرو بانک
Movement Recap: Can Humacyte Inc sustain earnings growthEarnings Risk Summary & Low Drawdown Trading Techniques - خودرو بانک
Guidance Update: Can Humacyte Inc deliver consistent EPS growthTrade Analysis Summary & AI Forecasted Entry and Exit Points - خودرو بانک
Aug Drivers: Is La Z Boy Incorporated exposed to political risk2025 Retail Activity & Long-Term Growth Portfolio Plans - خودرو بانک
Value Recap: What analysts say about Humacyte Inc Equity Warrant stock2025 Performance Recap & Capital Efficiency Focused Ideas - خودرو بانک
Humacyte, Inc. Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess - MarketScreener
Aug EndMonth: What are the analyst revisions for Air T IncIs Humacyte Inc stock a good investment in YEAR - خودرو بانک
Humacyte reports positive outcomes for Symvess in vascular repairs - Investing.com India
EPS Watch: What are the analyst revisions for Air T IncIs Humacyte Inc stock a good investment in YEAR2025 Key Highlights & Accurate Intraday Trade Tips - خودرو بانک
Humacyte reports positive outcomes for Symvess in vascular repairs By Investing.com - Investing.com Nigeria
Humacyte, Inc. Announces Positive Outcomes for Symvess in Journal of Vascular Surgery Publication - Quiver Quantitative
Zero Infections, 100% Limb Salvage: Humacyte's Bioengineered Blood Vessel Shows Promise in Hospital Injuries - Stock Titan
Is Humacyte Inc Equity Warrant stock heavily shortedWeekly Market Summary & Real-Time Buy Zone Alerts - خودرو بانک
Humacyte Stock Hits Over 1-Month Highs On FDA Nod For Bioengineered Tissue In Treating Vascular Trauma, Retail Interest Soars - MSN
Humacyte Inc files for mixed shelf of up to $350 millionSEC filing - MarketScreener
Polar Asset Management Partners Inc. Buys Shares of 500,000 Humacyte, Inc. $HUMA - MarketBeat
294,392 Shares in Humacyte, Inc. $HUMA Bought by Nuveen LLC - MarketBeat
Can Humacyte Inc. deliver consistent EPS growthInsider Selling & AI Driven Stock Movement Reports - Lancaster City Council
Update Report: What are Humacyte Inc.’s technical support levelsJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - Lancaster City Council
Does Humacyte Inc. stock have upside surprise potentialInsider Buying & Risk Controlled Stock Alerts - beatles.ru
How do insiders feel about Humacyte Inc. Equity WarrantDollar Strength & AI Driven Stock Price Forecasts - 뉴스영
3,312,356 Shares in Humacyte, Inc. $HUMA Purchased by RA Capital Management L.P. - MarketBeat
What data driven models say about Humacyte Inc. Equity Warrant’s futureJuly 2025 Gainers & Precise Buy Zone Identification - Newser
Humacyte, Senseonics jump as Barclays issues new Overweight ratings - MSN
Is now the right time to enter Humacyte Inc. Equity Warrant2025 Major Catalysts & Proven Capital Preservation Methods - خودرو بانک
Is Humacyte Inc. backed by strong institutional buyingJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - خودرو بانک
What technical models suggest about Humacyte Inc.’s comeback2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.14%
자본화:
|
볼륨(24시간):